Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07421102 · ClinicalTrials.gov registry record · Early Phase 1
Pilot of Mailing Buprenorphine
A Early Phase 1 study, sponsored by Medical University of South Carolina.
- Recruiting
- Registry status
- Early Phase 1
- Development phase
- 20
- Enrollment target
NCT07421102 is a Early Phase 1 study that is actively recruiting participants, run by Medical University of South Carolina. The registered enrollment target is 20 participants.
The verdict
NCT07421102, a Early Phase 1 study, is actively recruiting participants, sponsored by Medical University of South Carolina.
- RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 20 participants
- Enrollment target
Study Summary
This pilot study evaluates the feasibility, acceptability, and preliminary effectiveness of mailing buprenorphine to individuals with opioid use disorder (OUD) following medical hospitalization. The intervention aims to improve retention in treatment by overcoming barriers such as transportation and pharmacy access.
Interventions
- OTHER strategy of mailing buprenorphine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2026-04 |
| Est. Completion | 2027-03 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07421102
The ClinicalTrials.gov registry entry for NCT07421102 describes a study currently listed as recruiting, categorized as Early Phase 1. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which strategy of mailing buprenorphine is the first listed.
NCT07421102 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07421102 about?
NCT07421102 is a clinical study titled "Pilot of Mailing Buprenorphine". This pilot study evaluates the feasibility, acceptability, and preliminary effectiveness of mailing buprenorphine to individuals with opioid use disorder (OUD) following medical hospitalization. The intervention aims to improve retention in treatment by overcoming barriers such as transportation and...
What is the current status of trial NCT07421102?
This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 20 participants. The study started on 2026-04. Estimated completion is 2027-03.
What interventions are being tested in trial NCT07421102?
The interventions under investigation include: strategy of mailing buprenorphine (OTHER).
Who is sponsoring clinical trial NCT07421102?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.